Skip to main content
. 2021 May 7;22:331. doi: 10.1186/s13063-021-05278-6

Table 2.

Elements of the completely specified primary outcomes

Domain Measurement Metric Aggregation Time-point
Quality of life SF-12 Change from baseline Mean

At week 12 (end of treatment)

At week 48 (end of follow-up)

Walking speed Gait analysis Change from baseline Mean At week 12 (end of treatment)
Postural sway area Stabilometry Change from baseline Mean At week 12 (end of treatment)